Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.50 |
| ▸ | FABP6 | P51161 | 1/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.45 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.45 |
| ▸ | METAP1 | P53582 | 2/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | CBFB | Q13951 | 1/20 | 0.43 |
| ▸ | TDP2 | O95551 | 1/20 | 0.43 |
| ▸ | NGF | P01138 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lumichrome SCHEMBL30432151 | 1.00 | ATM (0.50) | ATMNPC1RAB9AERAP1FABP6 | |
| SCHEMBL3472182 | 0.88 | RAB9A (0.36) | ATMNPC1RAB9AERAP1PDGFRB | |
| SCHEMBL24805247 | 0.88 | ATM (0.40) | ATMNPC1RAB9AERAP1FABP6 | |
| SCHEMBL3473707 | 0.79 | KMT2A (0.53) | NPC1RAB9APDGFRBFGFR1KDR | |
| SCHEMBL9159930 | 0.78 | MEN1 (0.41) | ATMNPC1RAB9AERAP1MEN1 | |
| SCHEMBL21995498 | 0.75 | MEN1 (0.55) | NPC1RAB9AMEN1MAPTKMT2A | |
| SCHEMBL24238258 | 0.75 | HPGD (0.51) | NPC1RAB9AMEN1MAPTKMT2A | |
| SCHEMBL1170803 | 0.74 | FABP6 (0.63) | ATMNPC1RAB9AERAP1FABP6 | |
| SCHEMBL30038044 | 0.74 | FABP6 (0.63) | ATMNPC1RAB9AERAP1FABP6 | |
| Alloxazine SCHEMBL57289 | 0.73 | RAB9A (0.60) | NPC1RAB9APDGFRBFGFR1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626988-A1 | BIO BASED NATURAL RUBBER SOLUTIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-10-08 | — | — | EP | claimed |
| WO-2024115671-A1 | BIO BASED NATURAL RUBBER SOLUTIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) | 2024-06-06 | — | — | WO | claimed |
| EP-4379008-A1 | BIO BASED NATURAL RUBBER SOLUTIONS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2024-06-05 | — | — | EP | claimed |
| US-20230391894-A1 | PROCESS FOR OBTAINING NATURAL RUBBER, RUBBER COMPOSITION CONTAINING NATURAL RUBBER AND USE THEREOF | CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) | 2023-12-07 | — | — | US | claimed |
| EP-4217209-A1 | PROCESS FOR OBTAINING NATURAL RUBBER, RUBBER COMPOSITION CONTAINING NATURAL RUBBER AND USE THEREOF | Continental Reifen Deutschland GmbH (DE) | 2023-08-02 | — | — | EP | claimed |
| CN-116194307-A | Method for obtaining natural rubber, rubber composition containing natural rubber and use thereof | 大陆轮胎德国有限公司 | 2023-05-30 | — | — | CN | claimed |
| US-20230148252-A1 | PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION | L'OREAL (FR) | 2023-05-11 | — | — | US | claimed |
| WO-2022063623-A1 | PROCESS FOR OBTAINING NATURAL RUBBER, RUBBER COMPOSITION CONTAINING NATURAL RUBBER AND USE THEREOF | CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) | 2022-03-31 | — | — | WO | claimed |
| EP-3727318-B1 | PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION | OREAL (FR) | 2022-01-19 | — | — | EP | claimed |
| US-20200375866-A1 | HAIR TREATMENT PROCESS USING A FLAVIN DERIVATIVE AND LIGHT RADIATION | L'OREAL (FR) | 2020-12-03 | — | — | US | claimed |
| EP-0952184-A1 | Rubber composition | Continental Aktiengesellschaft (DE) | 1999-10-27 | — | — | EP | claimed |
| EP-4036246-B1 | A METHOD FOR TRANSPARENTIZING BIOLOGICAL TISSUE IN A LIVING STATE | UNIV OSAKA (JP) | 2025-04-09 | — | — | EP | disclosed |
| US-20250041430-A1 | CONJUGATE COMPOUND AND METHOD FOR PRODUCING CONJUGATE COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 2025-02-06 | — | — | US | disclosed |
| US-20240358625-A1 | STABILIZATION OF MYCOSPORINE-LIKE AMINO ACIDS | NAGASE & CO., LTD. (JP) | 2024-10-31 | — | — | US | disclosed |
| EP-4385506-A1 | STABILIZATION OF MYCOSPORINE-LIKE AMINO ACID | Nagase & Co., Ltd. (JP) | 2024-06-19 | — | — | EP | disclosed |
| EP-0234313-B1 | COMPOSITION AND METHOD FOR STABILIZATION OF DINUCLEOTIDES | ABBOTT LABORATORIES (US) | 1993-03-10 | — | — | EP | disclosed |
| US-4704365-A | Composition and method for stabilization of dinucleotides | ABBOTT LABORATORIES (US) | 1987-11-03 | — | — | US | disclosed |
| EP-0030550-A1 | ANTIHYPERTENSIVE AGENTS AND THEIR USE IN TREATMENT OF HYPERTENSION | TRACHEWSKY, Daniel (US) | 1981-06-24 | — | — | EP | disclosed |
| US-4264601-A | SUBSTITUTED ISOALLOXAZINES | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 1981-04-28 | — | — | US | disclosed |
| WO-1980002799-A1 | ANTIHYPERTENSIVE AGENTS AND THEIR USE IN TREATMENT OF HYPERTENSION | TRACHEWSKY D | 1980-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041430-A1 | CONJUGATE COMPOUND AND METHOD FOR PRODUCING CONJUGATE COMPOUND | C9, C3AR1, C5AR1 | ATM 3159/4885NPC1 1911/4885RAB9A 3074/4885 |
| US-20240358625-A1 | STABILIZATION OF MYCOSPORINE-LIKE AMINO ACIDS | GDA, MYCBP, MYC | ATM 1308/4885NPC1 3801/4885RAB9A 3237/4885 |
| US-20230148252-A1 | PROCESS FOR TREATING KERATIN MATERIALS USING A FLAVIN DERIVATIVE, A POLYMERIZABLE MOLECULE AND LIGHT RADIATION | KRT18, FLNA, VIM | ATM 352/4885NPC1 4828/4885RAB9A 4382/4885 |
| US-20200375866-A1 | HAIR TREATMENT PROCESS USING A FLAVIN DERIVATIVE AND LIGHT RADIATION | FH, BLVRB, NQO1 | ATM 1695/4885NPC1 4813/4885RAB9A 4747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.